Tyrophentide

替芬泰

Report date: 2025/05/27 11:35:42
NME

Base Information

Drug NameTyrophentide
Drug Alias NameBentysrepinineTyrophentidiumY-101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHepatitis B virus replication inhibitorsDNA synthesis inhibitorsHBV DNA Polymerase inhibitors
TargetsHBV DNA Polymerase
Therapy Area/IndicationsHepatitis B, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaPending
Originator CompaniesThe Key Laboratory Of Chemistry For Guizhou Province And Chinese Academy Of SciencesNo 302 Hospital Of The People Liberation Army Of ChinaGuizhou Bailing Group Pharmaceutical Co Ltd +[4] 
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesN/A
Inactive CompaniesNo 302 Hospital Of The People Liberation Army Of ChinaThe Key Laboratory Of Chemistry For Guizhou Province And Chinese Academy Of SciencesTianjin Remedy Research Institute +[4] 
Active IndicationsN/A
Inactive IndicationsHepatitis B, Chronic

Other Information

ATC CodeN/A
Related LinksN/A